Both in Pharmaceuticals
ArriVent BioPharma vs Obsidian Therapeutics
Over the past year AVBP returned −42.6% and OBX returned −33.9%; their daily moves had a correlation of 0.18.
AVBP −42.6% OBX −33.9%Growth of $1, one year, split-adjusted
| Metric | AVBP | OBX |
|---|---|---|
| Price | $16.66 | $11.77 |
| Market cap | $821.5M | $727.1M |
| Today | −0.77% | −3.52% |
| 1 month | −41.3% | −32.7% |
| 6 months | −43.8% | — |
| Year to date | −17.2% | — |
| 1 year | −19.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $373.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 137.5% | — |
| Short % of float | 25.6% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).